Amgen Inc (NAS:AMGN)
$ 264.49 0.49 (0.19%) Market Cap: 142.17 Bil Enterprise Value: 193.56 Bil PE Ratio: 33.87 PB Ratio: 18.89 GF Score: 89/100

Amgen Inc at Cowen Health Care Conference Transcript

Mar 08, 2023 / 04:10PM GMT
Release Date Price: $228.43 (-0.13%)
Yaron Benjamin Werber
TD Cowen, Research Division - MD & Senior Biotechnology Analyst

Once again to the 43rd Annual Healthcare Conference, and it's actually the first TD Cowen Healthcare Conference. I'm Yaron Werber, biotech analyst here at TD Cowen. And it's a great pleasure to moderate the next fireside chat with Amgen, and the management really needs no introduction, all the way to at the left at the end is Peter Griffith, who's EVP and Chief Financial Officer; and to his right is Murdo Gordon, who's our EVP of Global Commercial Ops. Gentlemen, good to see you. Thank you so much for joining.

Peter H. Griffith
Amgen Inc. - Executive VP & CFO

Great to be here.

Yaron Benjamin Werber;Murdo Gordon
TD Cowen, Research Division - MD & Senior Biotechnology Analyst;Amgen Inc.

And for many of you who've been at the lobby, you can see there's actually a video. I'm talking about innovators in biotech and Murdo's on the video with us. We shot that at JPMorgan about 1.5 months ago.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot